Stockscreener 앱 받기
1.24
0.80%
-0.01
Hookipa Pharma Inc 주식(HOOK)의 최신 뉴스
Millennium Management LLC Purchases Shares of 15,326 Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
Squarepoint Ops LLC Takes $104,000 Position in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
Gilead to buy certain Hookipa Pharma assets for up to $10M - MSN
Gilead (GILD) to Acquire HOOK for $10 million - MSN
Gilead Sciences to Acquire HOOKIPA Pharma Assets for $10M - GuruFocus
Hookipa Pharma (NASDAQ:HOOK) Trading Up 6.6% – Time to Buy? - Defense World
HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise - marketscreener.com
Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) - Seeking Alpha
Poolbeg Pharma plc (AIM:POLB) Increase of BookBuild Offer - Share Talk
HOOKIPA Pharma Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView
The Significance of Moving Averages in Hookipa Pharma Inc Inc. (HOOK) Price Performance - investchronicle.com
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - Defense World
Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Drops By 75.2% - The AM Reporter
Hookipa Pharma stock hits 52-week low at $0.81 amid sharp decline - Investing.com India
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline By Investing.com - Investing.com South Africa
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday - Defense World
HOOKIPA Pharma to participate in upcoming investor conferences in September - marketscreener.com
Hookipa Pharma (HOOK) Expected to Announce Earnings on Thursday - Defense World
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com Australia
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline By Investing.com - Investing.com South Africa
HOOKIPA Pharma Inc. SEC 10-K Report - TradingView
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn By Investing.com - Investing.com South Africa
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN
BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World
Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk
Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors USA
Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewswire
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma - Investing.com India
Failed Merger: Why HOOKIPA Pharma Walked Away from Poolbeg Deal - StockTitan
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance
Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World
HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria
0.99%
0.39%
자본화:
|
볼륨(24시간):